Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Catastrophic consequences??

Nearly a year ago, Dr. Fauci touted ZYESAMI as a promising treatment for COVID-19. However, the drug appears no closer to receiving FDA approval. Meanwhile, treatments including remdesivir, Molnupiravir, Paxlovid and the COVID-19 vaccines were fast tracked to approval.

The members are seeking an explanation for the delayed review process and favoritism shown by federal health agencies for large drug manufacturers.

https://www.wispolitics.com/2022/u-s-sen-johnson-leads-colleagues-in-demanding-answers-from-dr-califf-and-dr-fauci/

The senator wrote, “Based on data from the Defense Medical Epidemiology Database (DMED), Thomas Renz, an attorney who is representing three Department of Defense (DoD) whistleblowers, reported that these whistleblowers found a significant increase in registered diagnoses on DMED for miscarriages, cancer, and many other medical conditions in 2021 compared to a five-year average from 2016-2020. For example, at the roundtable Renz stated that registered diagnoses for neurological issues increased 10 times from a five-year average of 82,000 to 863,000 in 2021.”

Senator Johnson also raised concerns that “some DMED data showing registered diagnoses of myocarditis had been removed from the database.”

The full text of the letter can be found here and below.

Read more coverage regarding the senator’s oversight efforts at The Blaze: Military spokesman claims 5 random years of DOD medical surveillance system were plagued by a giant glitch

https://www.ronjohnson.senate.gov/2022/2/sen-johnson-to-secretary-austin-has-dod-seen-an-increase-in-medical-diagnoses-among-military-personnel